ZeClinics Overview

  • Founded
  • 2013

  • Status
  • Private

  • Employees
  • 38

  • Latest Deal Type
  • Angel

  • (Cancelled)
  • Latest Deal Amount
  • $5.67M

  • Investors
  • 1

ZeClinics General Information


Developer of a biotechnology platform designed to develop drugs and pharmaceuticals using zebrafish. The company's platform tracks toxicity data, preserves embryos of marine species, tests and utilizes zebrafish larvae in toxicology screening of drugs and related protein molecules, enabling biotechnologists to test the toxicity of drugs and recommend dosage with the help of zebrafish screening and nullification.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • C/Marina 25-27
  • 08005 Barcelona
  • Spain
+34 930 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ZeClinics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 19-Jan-2022 $5.67M Cancelled Generating Revenue
2. Grant 01-Dec-2016 00.000 00000 Completed Generating Revenue
1. Equity Crowdfunding 31-May-2015 $112K $112K 00.000 Completed Generating Revenue
To view ZeClinics’s complete valuation and funding history, request access »

ZeClinics Executive Team (4)

Name Title Board Seat Contact Info
Simone Calzolari Ph.D Co-Founder, Chief Executive Officer & Board Member
Ignasi Sahún Abizanda Ph.D Co-Founder, Chief Operating Officer & Board Member
Javier Terriente Ph.D Co-Founder, Chief of Drug Development & Board Member
Davide D'Amico Ph.D Co-Founder & Chairman
To view ZeClinics’s complete executive team members history, request access »

ZeClinics Board Members (4)

Name Representing Role Since
Davide D'Amico Ph.D ZeClinics Co-Founder & Chairman 000 0000
Ignasi Sahún Abizanda Ph.D ZeClinics Co-Founder, Chief Operating Officer & Board Member 000 0000
Javier Terriente Ph.D ZeClinics Co-Founder, Chief of Drug Development & Board Member 000 0000
Simone Calzolari Ph.D ZeClinics Co-Founder, Chief Executive Officer & Board Member 000 0000
To view ZeClinics’s complete board members history, request access »

ZeClinics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ZeClinics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 SME Instrument Government 000 0000 000000 0
To view ZeClinics’s complete investors history, request access »